• PRELADENANT CHEMBL240624

    Alternate Names:

    SCH-420814
    MK-3814
    Preladenant
    10117987
    7-(2-(4-(2,4-DIFLUOROPHENYL)PIPERAZIN-1-YL)ETHYL)-2-(FURAN-2-YL)-7H-PYRAZOLO[4,3-E][1,2,4]TRIAZOLO[1,5-C]PYRIMIDIN-5-AMINE
    4-(FURAN-2-YL)-10-(2-{4-[4-(2-METHOXYETHOXY)PHENYL]PIPERAZIN-1-YL}ETHYL)-3,5,6,8,10,11-HEXAAZATRICYCLO[7.3.0.0(2),?]DODECA-1(9),2,4,7,11-PENTAEN-7-AMINE
    2-FURAN-2-YL-7-(2-{4-[4-(2-METHOXY-ETHOXY)-PHENYL]-PIPERAZIN-1-YL}-ETHYL)-7H-PYRAZOLO[4,3-E][1,2,4]TRIAZOLO[1,5-C]PYRIMIDIN-5-YLAMINE
    2-FURAN-2-YL-7-(2-{4-[4-(2-METHOXY-ETHOXY)-PHENYL]-PIPERAZIN-1-YL}-ETHYL)-2,7-DIHYDRO-3H-PYRAZOLO[4,3-E][1,2,4]TRIAZOLO[1,5-C]PYRIMIDIN-5-YLAMINE
    2-(2-FURANYL)-7-[2-[4-[4-(2-METHOXYETHOXY)PHENYL]-1-PIPERAZINYL]ETHYL]-7H-PYRAZOLO[4,3-E][1,2,4]TRIAZOLO[1,5-C]PYRIMIDIN-5-AMINE
    W-5675
    D09717
    FT-0674026
    4CH-002230
    TC-157862
    ST2413698
    AJ-112150
    AB0069726
    PL009986
    HY-10889
    DA-42600
    BC283075
    AK-43905
    CS-0999
    AKOS016006028
    ZINC53006885
    DCL000979
    BDBM50202986
    ANW-69117
    4830AB
    C25H29N9O3
    MOLPORT-023-333-316
    CHEBI:510123
    CTK8C2839
    SCHEMBL2856554
    GTPL5614
    950O97NUPO
    PRELADENANT (USAN/INN)
    CID 10117987
    CID10117987
    SCH420814
    7H-PYRAZOLO(4,3-E)(1,2,4)TRIAZOLO(1,5-C)PYRIMIDIN-5-AMINE, 2-(2-FURANYL)-7-(2-(4-(4-(2-METHOXYETHOXY)PHENYL)-1-PIPERAZINYL)ETHYL)-
    2-FURAN-2-YL-7-(2-{4-[4-(2-METHOXYETHOXY)PHENYL]PIPERAZIN-1-YL}ETHYL)-7H-PYRAZOLO[4,3-E][1,2,4]TRIAZOLO[1,5-C]PYRIMIDIN-5-YLAMINE
    L021041
    UNII-950O97NUPO
    SCH 420814
    377727-87-2
    9895066
    623174-20-9
    47207667
    178102248
    5614

    Drug Info:

    FDA Approval not approved
    Drug Class small molecule
    Drug Indications antiparkinson agent
    (1 More Sources)

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Trial Name preladenant, SCH-420814
    Novel drug target Established target
    Specific Action of the Ligand Antagonist

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Mechanism of Interaction Adenosine A2a receptor antagonist
    Direct Interaction yes
    Specific Action of the Ligand Antagonist

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Specific Action of the Ligand Antagonist
    Endogenous Drug? False

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Specific Action of the Ligand Antagonist
    Endogenous Drug? False

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antiparkinson agent
    Drug Class small molecule
    FDA Approval not approved

    Publications:

    • Version: 09-Feb-2016

    Alternate Names:
    PRELADENANT pubchem_primary_name
    10117987 PubChem CID
    377727-87-2 Drug Synonym

    Drug Info:

    Publications:

    • Version: 27-September-2017

    Alternate Names:
    PRELADENANT GuideToPharmacology Ligand Name
    178102248 PubChem Drug SID

    Drug Info:

    Publications:

    • Version: 4.3.02 (25-August-2011)

    Alternate Names:
    SCH 420814 Drug Synonym
    PRELADENANT Drug Synonym
    7H-PYRAZOLO(4,3-E)(1,2,4)TRIAZOLO(1,5-C)PYRIMIDIN-5-AMINE, 2-(2-FURANYL)-7-(2-(4-(4-(2-METHOXYETHOXY)PHENYL)-1-PIPERAZINYL)ETHYL)- Drug Synonym

    Drug Info:

    Publications:

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: